Compile Data Set for Download or QSAR
Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 50012175
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM15581(US8633208, Clorgyline | [3-(2,4-dichlorophenoxy)pr...)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555063(CHEMBL4747396)
Affinity DataIC50: 21nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555065(CHEMBL4749026)
Affinity DataIC50: 26nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555055(CHEMBL4750661)
Affinity DataIC50: 28nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555066(CHEMBL4763805)
Affinity DataIC50: 35nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555062(CHEMBL4792241)
Affinity DataIC50: 46nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555054(CHEMBL4743831)
Affinity DataIC50: 61nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555060(CHEMBL4781289)
Affinity DataIC50: 68nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555053(CHEMBL4752402)
Affinity DataIC50: 69nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555059(CHEMBL4786719)
Affinity DataIC50: 93nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555067(CHEMBL4758344)
Affinity DataIC50: 204nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM15579(US8633208, Deprenyl | CHEMBL972 | L-Deprenyl | SLG...)
Affinity DataIC50: 221nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM19187(CHEMBL396778 | (2S)-2-[({4-[(3-fluorophenyl)methox...)
Affinity DataIC50: 249nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555064(CHEMBL4741730)
Affinity DataIC50: 258nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555058(CHEMBL4786983)
Affinity DataIC50: 320nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555057(CHEMBL4790118)
Affinity DataIC50: 530nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555069(CHEMBL4786410)
Affinity DataIC50: 1.07E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555061(CHEMBL4763989)
Affinity DataIC50: 1.42E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555068(CHEMBL4787223)
Affinity DataIC50: 1.42E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555056(CHEMBL4786012)
Affinity DataIC50: 1.66E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555066(CHEMBL4763805)
Affinity DataIC50: 2.13E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555074(CHEMBL4779131)
Affinity DataIC50: 2.21E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555070(CHEMBL4799739)
Affinity DataIC50: 2.87E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555075(CHEMBL4743721)
Affinity DataIC50: 5.41E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555060(CHEMBL4781289)
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555073(CHEMBL4781503)
Affinity DataIC50: 6.35E+3nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555058(CHEMBL4786983)
Affinity DataIC50: 6.40E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555057(CHEMBL4790118)
Affinity DataIC50: 7.79E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555064(CHEMBL4741730)
Affinity DataIC50: 8.65E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555059(CHEMBL4786719)
Affinity DataIC50: 8.71E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555054(CHEMBL4743831)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555053(CHEMBL4752402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555072(CHEMBL4759613)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] B(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555071(CHEMBL4778977)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-B expressed in Sf9 cells using benzylamine as substrate preincubated for 15 mins followed by substrate addition f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555061(CHEMBL4763989)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555055(CHEMBL4750661)
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555069(CHEMBL4786410)
Affinity DataIC50: 1.45E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555068(CHEMBL4787223)
Affinity DataIC50: 1.75E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555062(CHEMBL4792241)
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555065(CHEMBL4749026)
Affinity DataIC50: 1.86E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555063(CHEMBL4747396)
Affinity DataIC50: 2.68E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555067(CHEMBL4758344)
Affinity DataIC50: 3.42E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555070(CHEMBL4799739)
Affinity DataIC50: 5.76E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM19187(CHEMBL396778 | (2S)-2-[({4-[(3-fluorophenyl)methox...)
Affinity DataIC50: 6.74E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Sunshine Lake Pharma

Curated by ChEMBL
LigandPNGBDBM50555056(CHEMBL4786012)
Affinity DataIC50: 7.52E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed